Dx & Vx Co., Ltd. (KOSDAQ:180400)
South Korea · Delayed Price · Currency is KRW 4,895.00
-125.00 (-2.49%)
At close: Apr 9, 2026
Dx & Vx Market Cap
Dx & Vx has a market cap or net worth of 485.25 billion as of April 10, 2026. Its market cap has increased by 449.87% in one year.
Market Cap
485.25B
Enterprise Value
430.04B
Revenue
29.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,895.00
Market Cap Chart
Since November 20, 2015, Dx & Vx's market cap has increased from 75.32B to 485.25B, an increase of 544.29%. That is a compound annual growth rate of 19.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 485.25B | 213.99% |
| Dec 30, 2025 | 154.55B | 68.91% |
| Dec 30, 2024 | 91.50B | -48.77% |
| Dec 28, 2023 | 178.59B | 52.96% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3billion | 362.08B |
| GENINUS | 160.24B |
| HLB Panagene | 104.36B |
| Cytogen | 88.47B |
| Green Cross Medical Science | 77.84B |
| Protia | 57.43B |
| Seoulin Bioscience | 53.40B |
| GeneMatrix | 38.73B |